Jonathan Allan

Jonathan Allan appears in our data through filings on Stoke Therapeutics, Inc. shares, published by SEC (Form 4). We count 29 filings; the first trade dates from 21 June 2023 and the latest from 2 October 2026.

Sales make up the whole of the open-market record (17 sales, €1.3M). The totals exclude 1 filing filed without an amount. Other entries cover 12 option exercises. So far in 2026, the count stands at no purchases and 7 sales.

The record was last updated on 2 October 2026 with an open-market sale (€15k) in Stoke Therapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.